These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
767 related articles for article (PubMed ID: 26154342)
1. Synthetic Nanoparticles for Vaccines and Immunotherapy. Irvine DJ; Hanson MC; Rakhra K; Tokatlian T Chem Rev; 2015 Oct; 115(19):11109-46. PubMed ID: 26154342 [No Abstract] [Full Text] [Related]
2. Bioconjugate Materials in Vaccines and Immunotherapies. Jewell CM; Caruso F Bioconjug Chem; 2018 Mar; 29(3):571. PubMed ID: 29558810 [No Abstract] [Full Text] [Related]
3. B Cells Loaded with Synthetic Particulate Antigens: A Versatile Platform To Generate Antigen-Specific Helper T Cells for Cell Therapy. Sicard A; Koenig A; Graff-Dubois S; Dussurgey S; Rouers A; Dubois V; Blanc P; Chartoire D; Errazuriz-Cerda E; Paidassi H; Taillardet M; Morelon E; Moris A; Defrance T; Thaunat O Nano Lett; 2016 Jan; 16(1):297-308. PubMed ID: 26650819 [TBL] [Abstract][Full Text] [Related]
4. Clustered carbohydrates in synthetic vaccines. Peri F Chem Soc Rev; 2013 Jun; 42(11):4543-56. PubMed ID: 23250562 [TBL] [Abstract][Full Text] [Related]
5. Synthetic glycopeptides for the development of cancer vaccines. Liakatos A; Kunz H Curr Opin Mol Ther; 2007 Feb; 9(1):35-44. PubMed ID: 17330400 [TBL] [Abstract][Full Text] [Related]
6. Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles. Varypataki EM; Silva AL; Barnier-Quer C; Collin N; Ossendorp F; Jiskoot W J Control Release; 2016 Mar; 226():98-106. PubMed ID: 26876760 [TBL] [Abstract][Full Text] [Related]
7. Novel vaccines and adjuvants for allergen-specific immunotherapy. Crameri R; Rhyner C Curr Opin Immunol; 2006 Dec; 18(6):761-8. PubMed ID: 17010585 [TBL] [Abstract][Full Text] [Related]
8. Lipopeptide Nanoparticles: Development of Vaccines against Hookworm Parasite. Fuaad AA; Pearson MS; Pickering DA; Becker L; Zhao G; Loukas AC; Skwarczynski M; Toth I ChemMedChem; 2015 Oct; 10(10):1647-54. PubMed ID: 26269385 [TBL] [Abstract][Full Text] [Related]
9. Recombinant helical plant virus-based nanoparticles for vaccination and immunotherapy. Narayanan KB; Han SS Virus Genes; 2018 Oct; 54(5):623-637. PubMed ID: 30008053 [TBL] [Abstract][Full Text] [Related]
10. Synthetic peptide vaccines: the quest to develop peptide vaccines for influenza, HIV and Alzheimer's disease. Bianchi E; Ingallinella P; Finotto M; Joyce J; Liang X; Miller MD; Kinney GG; Ciliberto G; Shiver JW; Pessi A Adv Exp Med Biol; 2009; 611():121-3. PubMed ID: 19400121 [No Abstract] [Full Text] [Related]
13. [Immunotherapy with recombinant house dust mite group 2 allergen vaccine inhibits allergic airway inflammation in mice]. Yu HQ; Liu ZG; Yu KY; Xu ZQ; Qiu J Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Dec; 24(6):414-9. PubMed ID: 17366969 [TBL] [Abstract][Full Text] [Related]
14. Editorial: Epitope Discovery and Synthetic Vaccine Design. Palatnik-de-Sousa CB; Soares IS; Rosa DS Front Immunol; 2018; 9():826. PubMed ID: 29720983 [No Abstract] [Full Text] [Related]
15. Carbohydrate-based synthetic vaccines: does the synthesis of longer chains of carbohydrates make this a step ever closer? Chu KC; Wu CY Future Med Chem; 2012 Sep; 4(14):1767-70. PubMed ID: 23043471 [No Abstract] [Full Text] [Related]
16. Synthetic peptide vaccines. Sesardic D J Med Microbiol; 1993 Oct; 39(4):241-2. PubMed ID: 7692052 [No Abstract] [Full Text] [Related]